InvestorsObserver
×
News Home

What is Wall Street's Target Price for NeoGenomics, Inc. (NEO) Stock Monday?

Monday, October 04, 2021 10:41 AM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for NeoGenomics, Inc. (NEO) Stock Monday?

InvestorsObserver is giving NeoGenomics, Inc. (NEO) an Analyst Rating Rank of 60, meaning NEO is ranked higher by analysts than 60% of stocks. The average price target for NEO is $57.571 and analyst’s rate the stock as a Strong Buy.

Overall Score - 4.6
Wall Street analysts are rating NEO a Strong Buy today. Find out what this means to you and get the rest of the rankings on NEO!

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With NeoGenomics, Inc. Stock Today?

NeoGenomics, Inc. (NEO) stock is trading at $45.41 as of 10:40 AM on Monday, Oct 4, a loss of -$3.08, or -6.35% from the previous closing price of $48.49. The stock has traded between $45.32 and $47.67 so far today. Volume today is light. So far 310,645 shares have traded compared to average volume of 1,134,394 shares. Click Here to get the full Stock Report for NeoGenomics, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App